| Bristol-Myers Squibb Company | 20 | $155,976 | $150,000 – $163,645 |
| Gilead Sciences, Inc. | 12 | $137,409 | $134,337 – $144,880 |
| Pfizer Inc. | 7 | $137,218 | $124,599 – $194,486 |
| Kite Pharma Inc. | 7 | $145,371 | $143,280 – $148,117 |
| Eisai Inc. | 5 | $168,705 | $161,000 – $171,634 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $175,000 | $170,000 – $175,000 |
| Moderna Services, Inc. | 4 | $128,072 | $123,256 – $135,013 |
| ClinChoice Inc. | 4 | $161,402 | $158,108 – $166,288 |
| Arrowhead Pharmaceuticals, Inc. | 3 | $150,000 | $150,000 – $150,000 |
| AbbVie Inc. | 3 | $178,000 | $161,500 – $181,500 |
| Ephicacy Consulting Group, Inc | 2 | $155,000 | $155,000 – $155,000 |
| Abbvie Biotherapeutics Inc. | 2 | $195,832 | $195,832 – $195,832 |
| Eikon Therapeutics, Inc. | 2 | $157,373 | $150,873 – $163,873 |
| Edwards Lifesciences LLC | 2 | $176,062 | $176,062 – $176,062 |
| ITI, Inc. | 2 | $151,645 | $150,822 – $152,468 |
| Takeda Development Center Americas, Inc. | 2 | $171,079 | $169,540 – $172,618 |
| Verastem Inc. | 2 | $159,862 | $157,293 – $162,431 |
| Revolution Medicines, Inc. | 2 | $191,445 | $188,222 – $194,668 |
| Enanta Pharmaceuticals, Inc. | 1 | $161,803 | $161,803 – $161,803 |
| Corcept Therapeutics, Inc | 1 | $190,000 | $190,000 – $190,000 |
| Cytel Inc. | 1 | $150,537 | $150,537 – $150,537 |
| Calsoft Labs Inc | 1 | $107,000 | $107,000 – $107,000 |
| Prosoft Software Inc. | 1 | $127,954 | $127,954 – $127,954 |
| Kardigan, Inc. | 1 | $157,000 | $157,000 – $157,000 |
| Horizon Therapeutics USA, Inc. | 1 | $160,000 | $160,000 – $160,000 |
| PTC Therapeutics, Inc. | 1 | $149,000 | $149,000 – $149,000 |
| Sarah Cannon Research Institute Holdings, LLC | 1 | $153,931 | $153,931 – $153,931 |
| Regeneron Pharmaceuticals, Inc. | 1 | $198,000 | $198,000 – $198,000 |
| Symbiance Inc. | 1 | $90,120 | $90,120 – $90,120 |
| Softworld, LLC | 1 | $165,000 | $165,000 – $165,000 |